OBJECTIVES: Human CD34+ cells represent a heterogeneous population of immature cells which may differentiate to various cell types. The aim of the study was to determine angiogenesis regulating genes expression in CD34+ cells, their subpopulations, and during their differentiation induced by hematopoietic growth factors. MATERIAL AND METHODS: We have measured the expression of angiogenesis regulating genes angiopoietin-1 (Ang-1), angiopoietin-1 (Ang-2) and their receptor Tie-2, vascular endothelial growth factor (VEGF) and its receptors VEGFR-1 and VEGFR-2 in sorted population of CD34+ and CD34+/CD133+ cells from human cord blood and bone marrow, and in their differentiating progeny, using real time reverse transcriptase polymerase chain reaction. The hematopoietic differentiation of CD34+ cells was induced in semisolid or liquid differentiation supporting media containing appropriate hematopoietic growth factors. RESULTS: A higher expression of Ang-1, Ang-2, and Tie-2 mRNAs was detected in CD34+/CD133+ cord blood cells as compared with CD34-/CD133- fraction, but no expression of these genes was detected in burst-forming unit erythroid (BFU-E) nor colony-forming unit granulocyte macrophage (CFU-GM) colonies. The level of Ang-1 and Tie-2 mRNAs, but not that of Ang-2 mRNA gradually decreased during a 14-d incubation of cord blood CD34+ cells in a liquid culture. A significantly higher expression of VEGF mRNA was in BFU-E as compared with CFU-GM cell colonies and CD34+/CD133+ cells. VEGFR-1 mRNA was equally expressed in CD34+/CD133+ and CD34-/CD133- cells as well as in BFU-E and CFU-GM colonies. Expression of VEGFR-2 mRNA was detected at the borderline of method sensitivity only in CD34+/CD133+ cells. CONCLUSION: CD34+/CD133+ cord blood cells express Ang-1, Ang-2 and VEGF as well as their receptor mRNAs, suggesting a role of these cells in regulation both angiopoiesis and hematopoiesis.
OBJECTIVES:HumanCD34+ cells represent a heterogeneous population of immature cells which may differentiate to various cell types. The aim of the study was to determine angiogenesis regulating genes expression in CD34+ cells, their subpopulations, and during their differentiation induced by hematopoietic growth factors. MATERIAL AND METHODS: We have measured the expression of angiogenesis regulating genes angiopoietin-1 (Ang-1), angiopoietin-1 (Ang-2) and their receptor Tie-2, vascular endothelial growth factor (VEGF) and its receptors VEGFR-1 and VEGFR-2 in sorted population of CD34+ and CD34+/CD133+ cells from human cord blood and bone marrow, and in their differentiating progeny, using real time reverse transcriptase polymerase chain reaction. The hematopoietic differentiation of CD34+ cells was induced in semisolid or liquid differentiation supporting media containing appropriate hematopoietic growth factors. RESULTS: A higher expression of Ang-1, Ang-2, and Tie-2 mRNAs was detected in CD34+/CD133+ cord blood cells as compared with CD34-/CD133- fraction, but no expression of these genes was detected in burst-forming unit erythroid (BFU-E) nor colony-forming unit granulocyte macrophage (CFU-GM) colonies. The level of Ang-1 and Tie-2 mRNAs, but not that of Ang-2 mRNA gradually decreased during a 14-d incubation of cord blood CD34+ cells in a liquid culture. A significantly higher expression of VEGF mRNA was in BFU-E as compared with CFU-GM cell colonies and CD34+/CD133+ cells. VEGFR-1 mRNA was equally expressed in CD34+/CD133+ and CD34-/CD133- cells as well as in BFU-E and CFU-GM colonies. Expression of VEGFR-2 mRNA was detected at the borderline of method sensitivity only in CD34+/CD133+ cells. CONCLUSION:CD34+/CD133+ cord blood cells express Ang-1, Ang-2 and VEGF as well as their receptor mRNAs, suggesting a role of these cells in regulation both angiopoiesis and hematopoiesis.
Authors: Josef Neumüller; Sylvia-Emanuela Neumüller-Guber; Markus Lipovac; Wilhelm Mosgoeller; Monika Vetterlein; Margit Pavelka; Johannes Huber Journal: Histochem Cell Biol Date: 2006-06-10 Impact factor: 4.304
Authors: Thomas Aschacher; Olivia Aschacher; Katy Schmidt; Florian K Enzmann; Eva Eichmair; Bernhard Winkler; Zsuzsanna Arnold; Felix Nagel; Bruno K Podesser; Andreas Mitterbauer; Barbara Messner; Martin Grabenwöger; Günther Laufer; Marek P Ehrlich; Michael Bergmann Journal: Int J Mol Sci Date: 2022-04-25 Impact factor: 6.208
Authors: Abba C Zubair; Sunita Malik; Athena Paulsen; Masakazu Ishikawa; Christopher McCoy; Peter X Adams; David Amrani; Marco Costa Journal: Cytotherapy Date: 2010-04 Impact factor: 5.414
Authors: Ali S Arbab; Branislava Janic; Robert A Knight; Stasia A Anderson; Edyta Pawelczyk; Ali M Rad; Elizabeth J Read; Sunil D Pandit; Joseph A Frank Journal: FASEB J Date: 2008-06-12 Impact factor: 5.191
Authors: L R Galieva; Y O Mukhamedshina; E R Akhmetzyanova; Z E Gilazieva; S S Arkhipova; E E Garanina; A A Rizvanov Journal: Stem Cells Int Date: 2018-02-18 Impact factor: 5.443